Use of antineoplastic agents in cancer patients with HIV/AIDS

Por Rudek, Michelle A., Flexner, Charles, Ambinder, Richard F.
Publicado em 2011

Pharmacotherapy in cancer patients with HIV/AIDS

Por Beumer, Jan H., Venkataramanan, Raman, Rudek, Michelle A.
Publicado em 2014

Harmonization on renal function assessment is needed during early clinical development of oncology drugs

Por Rudek, Michelle A., Graham, Richard A., Ratain, Mark J.
Publicado no J Clin Oncol (2015)

Determination of Salirasib (S-trans, trans-farnesylthiosalicylic acid) in human plasma using liquid chromatography-tandem mass spectrometry

Por Zhao, Ming, He, Ping, Xu, Linping, Hidalgo, Manuel, Laheru, Dan, Rudek, Michelle A.
Publicado em 2008

A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine

Por Anders, Nicole M., Wanjiku, Teresia M., He, Ping, Azad, Nilofer S., Rudek, Michelle A.
Publicado no Biomed Chromatogr (2015)

A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma

Por Zhao, Ming, Rudek, Michelle A., Mnasakanyan, Aleksandr, Hartke, Carol, Pili, Roberto, Baker, Sharyn D.
Publicado em 2006

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

Por Franke, Ryan M., Carducci, Michael A., Rudek, Michelle A., Baker, Sharyn D., Sparreboom, Alex
Publicado em 2010

Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography–tandem mass spectrometry (LC/M...

Por Rais, Rana, Zhao, Ming, He, Ping, Xu, Linping, Deeken, John F., Rudek, Michelle A.
Publicado em 2012

Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis

Por Dutta, Noton K., Pinn, Michael L., Zhao, Ming, Rudek, Michelle A., Karakousis, Petros C.
Publicado em 2013

Bisphosphonamidate Clodronate Prodrug Exhibits Potent Anticancer Activity in Non-Small Cell Lung Cancer cells

Por Webster, Marie R., Zhao, Ming, Rudek, Michelle A., Hann, Christine L., Freel Meyers, Caren L.
Publicado em 2011

The effect of hepatic impairment on outcomes in phase 1 clinical trials in cancer subjects

Por Mansfield, Aaron S., Rudek, Michelle A., Vulih, Diana, Smith, Gary L., Harris, Pamela Jo, Ivy, S. Percy
Publicado no Clin Cancer Res (2016)

Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies

Por Rojas, Camilo, Stathis, Marigo, Polydefkis, Michael, Rudek, Michelle A, Zhao, Ming, Ebenezer, Gigi J, Slusher, Barbara S
Publicado em 2011

Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure

Por Rudek, Michelle A, Chang, Cathy Y., Steadman, Kenneth, Johnson, Michael D., Desai, Naveen, Deeken, John F.
Publicado em 2014

The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas

Por Grossman, Rachel, Rudek, Michelle A., Brastianos, Harry, Zadnik, Patti, Brem, Henry, Tyler, Betty, Blakeley, Jaishri O.
Publicado em 2012

Preclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinib

Por Deeken, John F., Beumer, Jan H., Anders, Nicole M., Wanjiku, Teresia, Rusnak, Milan, Rudek, Michelle A.
Publicado no Cancer Chemother Pharmacol (2015)

Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry

Por Li, Lie, Zhao, Ming, Navid, Fariba, Pratz, Keith, Smith, B. Doug, Rudek, Michelle A., Baker, Sharyn D.
Publicado em 2010

Reversible Disulfide Formation of the Glutamate Carboxypeptidase II Inhibitor E2072 Results in Prolonged Systemic Exposures In Vivo

Por Rais, Rana, Hoover, Randall, Wozniak, Krystyna, Rudek, Michelle A., Tsukamoto, Takashi, Alt, Jesse, Rojas, Camilo, Slusher, Barbara S.
Publicado em 2012

Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients

Por Villarroel, Maria Cristina, Pratz, Keith W., Xu, Linping, Wright, John J., Smith, B. Douglas, Rudek, Michelle A.
Publicado em 2011

Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)

Por Rais, Rana, Rojas, Camilo, Wozniak, Krystyna, Wu, Ying, Zhao, Ming, Tsukamoto, Takashi, Rudek, Michelle A, Slusher, Barbara S.
Publicado em 2013

Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters

Por Hu, Shuiying, Chen, Zhaoyuan, Franke, Ryan, Orwick, Shelley, Zhao, Ming, Rudek, Michelle A., Sparreboom, Alex, Baker, Sharyn D.
Publicado em 2009